Protalix Biotherapeutics, Inc. (PLX)
2.715
-0.02
(-0.55%)
USD |
NYAM |
Oct 07, 16:00
2.715
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Price : 2.715 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 2.74 | 2.76 | 2.65 | 2.73 | 934737.0 |
| Oct 05, 2026 | 2.68 | 2.74 | 2.65 | 2.71 | 984061.0 |
| Oct 02, 2026 | 2.70 | 2.72 | 2.64 | 2.71 | 947405.0 |
| Oct 01, 2026 | 2.77 | 2.77 | 2.60 | 2.68 | 1.589M |
| Sep 30, 2026 | 2.69 | 2.815 | 2.68 | 2.76 | 836259.0 |
| Sep 29, 2026 | 2.69 | 2.735 | 2.680 | 2.69 | 898556.0 |
| Sep 28, 2026 | 2.71 | 2.72 | 2.61 | 2.69 | 832815.0 |
| Sep 25, 2026 | 2.76 | 2.775 | 2.70 | 2.72 | 386025.0 |
| Sep 24, 2026 | 2.78 | 2.817 | 2.73 | 2.75 | 302700.0 |
| Sep 23, 2026 | 2.84 | 2.850 | 2.765 | 2.80 | 586410.0 |
| Sep 22, 2026 | 2.75 | 2.84 | 2.75 | 2.84 | 854901.0 |
| Sep 21, 2026 | 2.71 | 2.78 | 2.69 | 2.75 | 471379.0 |
| Sep 18, 2026 | 2.68 | 2.715 | 2.66 | 2.69 | 1.250M |
| Sep 17, 2026 | 2.71 | 2.725 | 2.68 | 2.70 | 321894.0 |
| Sep 16, 2026 | 2.68 | 2.705 | 2.62 | 2.68 | 1.059M |
| Sep 15, 2026 | 2.75 | 2.75 | 2.64 | 2.66 | 812742.0 |
| Sep 14, 2026 | 2.63 | 2.79 | 2.620 | 2.77 | 952160.0 |
| Sep 11, 2026 | 2.74 | 2.75 | 2.615 | 2.64 | 646807.0 |
| Sep 10, 2026 | 2.66 | 2.735 | 2.64 | 2.73 | 782524.0 |
| Sep 09, 2026 | 2.68 | 2.68 | 2.595 | 2.67 | 580004.0 |
| Sep 08, 2026 | 2.66 | 2.67 | 2.60 | 2.65 | 908364.0 |
| Sep 04, 2026 | 2.62 | 2.68 | 2.615 | 2.67 | 863718.0 |
| Sep 03, 2026 | 2.59 | 2.665 | 2.57 | 2.62 | 942012.0 |
| Sep 02, 2026 | 2.59 | 2.64 | 2.585 | 2.59 | 454863.0 |
| Sep 01, 2026 | 2.61 | 2.67 | 2.565 | 2.59 | 598263.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 2.665 |
| Taysha Gene Therapies, Inc. | 4.445 |
| Humacyte, Inc. | 0.4744 |
| Agenus, Inc. | 7.555 |
| Amgen, Inc. | 413.02 |
Price Related Metrics
| PE Ratio | 11.96 |
| PS Ratio | 2.752 |
| PEG Ratio | 0.0578 |
| Price to Book Value | 3.064 |
| Price to Free Cash Flow | 28.93 |
| Earnings Yield | 8.36% |
| Market Cap | 218.75M |
| PEGY Ratio | 0.0578 |
| Operating PE Ratio | 9.525 |
| Normalized PE Ratio | 11.96 |